Here is data found by MailMentor on Aiolos Bio
- Aiolos Bio is a biotech company focused on developing innovative therapies for respiratory diseases and immune conditions. With a recent series A investment of $245 million, Aiolos Bio is advancing the development of a novel TSLP antibody that is phase 2-ready. Their mission is to address the treatment needs of patients with respiratory and inflammatory conditions.
Find contacts at this company
Our AI enabled web scraper helps you prospects at Aiolos Bio and similar companiesFind out how